Osteoclast-derived Exosomal Mir-214-3p Inhibits Osteoblastic Bone Formation.
Defang Li,Jin Liu,Baosheng Guo,Chao Liang,Lei Dang,Cheng Lu,Xiaojuan He,Hilda Yeuk-Siu Cheung,Liang Xu,Changwei Lu,Bing He,Biao Liu,Atik Badshah Shaikh,Fangfei Li,Luyao Wang,Zhijun Yang,Doris Wai-Ting Au,Songlin Peng,Zongkang Zhang,Bao-Ting Zhang,Xiaohua Pan,Airong Qian,Peng Shang,Lianbo Xiao,Baohong Jiang,Chris Kong-Chu Wong,Jiake Xu,Zhaoxiang Bian,Zicai Liang,De-an Guo,Hailong Zhu,Weihong Tan,Aiping Lu,Ge Zhang
DOI: https://doi.org/10.1038/ncomms10872
IF: 16.6
2016-01-01
Nature Communications
Abstract:Emerging evidence indicates that osteoclasts direct osteoblastic bone formation. MicroRNAs (miRNAs) have a crucial role in regulating osteoclast and osteoblast function. However, whether miRNAs mediate osteoclast-directed osteoblastic bone formation is mostly unknown. Here, we show that increased osteoclastic miR-214-3p associates with both elevated serum exosomal miR-214-3p and reduced bone formation in elderly women with fractures and in ovariectomized (OVX) mice. Osteoclast-specific miR-214-3p knock-in mice have elevated serum exosomal miR-214-3p and reduced bone formation that is rescued by osteoclast-targeted antagomir-214-3p treatment. We further demonstrate that osteoclast-derived exosomal miR-214-3p is transferred to osteoblasts to inhibit osteoblast activity in vitro and reduce bone formation in vivo. Moreover, osteoclast-targeted miR-214-3p inhibition promotes bone formation in ageing OVX mice. Collectively, our results suggest that osteoclast-derived exosomal miR-214-3p transfers to osteoblasts to inhibit bone formation. Inhibition of miR-214-3p in osteoclasts may be a strategy for treating skeletal disorders involving a reduction in bone formation.